Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,760,000 | 5,661,000 | 5,115,000 | 3,928,000 | 2,184,000 |
| Depreciation Amortization | 354,000 | 1,546,000 | 1,140,000 | 753,000 | 373,000 |
| Income taxes - deferred | -274,000 | -279,000 | 43,000 | -226,000 | -174,000 |
| Accounts receivable | -1,174,000 | -2,526,000 | -3,282,000 | -4,097,000 | -3,174,000 |
| Accounts payable and accrued liabilities | 1,590,000 | 228,000 | -873,000 | 387,000 | 600,000 |
| Other Working Capital | 2,660,000 | -3,277,000 | -2,753,000 | -2,003,000 | -1,785,000 |
| Other Operating Activity | -584,000 | 2,937,000 | 4,816,000 | 4,329,000 | 2,993,000 |
| Operating Cash Flow | $4,332,000 | $4,290,000 | $4,206,000 | $3,071,000 | $1,017,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -313,000 | -385,000 | -576,000 | -466,000 | -290,000 |
| PPE Investments | -235,000 | -1,116,000 | -823,000 | -463,000 | -196,000 |
| Net Acquisitions | 5,000 | 88,000 | 55,000 | 54,000 | 4,000 |
| Purchase Of Investment | -4,735,000 | -15,026,000 | -12,265,000 | -8,102,000 | -3,964,000 |
| Sale Of Investment | 3,646,000 | 15,095,000 | 11,853,000 | 8,431,000 | 4,574,000 |
| Other Investing Activity | -10,000 | 0 | -52,000 | -38,000 | -25,000 |
| Investing Cash Flow | $-1,642,000 | $-1,344,000 | $-1,808,000 | $-584,000 | $103,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -115,000 | 3,203,000 | 1,643,000 | 1,097,000 | 836,000 |
| Debt Issued | N/A | 2,991,000 | 2,994,000 | 0 | N/A |
| Debt Repayment | -750,000 | -2,147,000 | -2,150,000 | -1,250,000 | -1,250,000 |
| Common Stock Issued | 37,000 | 79,000 | 21,000 | 21,000 | 23,000 |
| Common Stock Repurchased | -1,124,000 | -2,605,000 | -2,134,000 | -1,258,000 | -880,000 |
| Dividend Paid | -376,000 | -1,529,000 | -1,152,000 | -771,000 | -386,000 |
| Other Financing Activity | -187,000 | -1,730,000 | -1,196,000 | -56,000 | -252,000 |
| Financing Cash Flow | $-2,515,000 | $-1,738,000 | $-1,974,000 | $-2,217,000 | $-1,909,000 |
| Exchange Rate Effect | -9,000 | -5,000 | 1,000 | 2,000 | 1,000 |
| Beginning Cash Position | 9,491,000 | 8,288,000 | 8,288,000 | 8,288,000 | 8,288,000 |
| End Cash Position | 9,657,000 | 9,491,000 | 8,713,000 | 8,560,000 | 7,500,000 |
| Net Cash Flow | $166,000 | $1,203,000 | $425,000 | $272,000 | $-788,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,332,000 | 4,290,000 | 4,206,000 | 3,071,000 | 1,017,000 |
| Capital Expenditure | -235,000 | -1,116,000 | -823,000 | -463,000 | -196,000 |
| Free Cash Flow | 4,097,000 | 3,174,000 | 3,383,000 | 2,608,000 | 821,000 |